Cihexa ≥ 30 IU, ≥ 40 IU, ≥ 4 IU, 15 mcg, 40 DU, 8 DU, 32 DU, 10 mcg Suspension for injection
PDF Leaflet Revision Date: 08 October 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunisation against multiple diseases in infants.
Dosage (summary)
3 doses of 0.5 mL at 6, 10, and 14 weeks; booster at 12-24 months.
Special Populations
- Infants
- Immunocompromised
Pregnancy & Breastfeeding
Not intended for women of child-bearing age; data on pregnancy/lactation not available.
Key Drug Interactions
- Concomitant use with other vaccines
- Caution with anticoagulants
Contraindications
- Hypersensitivity to vaccine components
- Encephalopathy after previous vaccination
- Uncontrolled neurologic disorders
Common side effects
- Decreased appetite
- Somnolence
- Vomiting
- Injection site erythema
- Irritability
- Pyrexia
Counselling Points
- Shake vial before use
- Administer intramuscularly
- Observe for 30 mins post-injection
Serious warnings
- May not elicit immune response in all individuals
- Monitor for allergic reactions post-vaccination
Important Disclaimer
The Cihexa ≥ 30 IU, ≥ 40 IU, ≥ 4 IU, 15 mcg, 40 DU, 8 DU, 32 DU, 10 mcg Suspension for injection professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
